Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer
Journal of BioScience and Biotechnology · 01.07.2025
DOI: 10.69085/jbb20251007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of BioScience and Biotechnology, erschienen am 01.07.2025. Verfasst von Hasan N. Smeasm und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Bladder cancer (BC) is the most prevalent cancer found in the bladder system and is the tenth most common carcinoma worldwide. Pseudocholinesterase (PChE) is one of the serum proteins. Serum PChE has been recognized as an indicator of outcomes in several cancers; nevertheless, its correlation with oncological results in muscle-invasive bladder cancer (MIBC) and Non-muscle-invasive bladder cancer (NMIBC) remains largely unexamined. The study aims to assess the association of the PChE levels and lipid indices, including the atherogenic index of plasma (AIP), Castelli's risk index II (CRI-II), and the atherogenic coefficient (AC), with the development of MIBC and to use them as indicators of the development of MIBC in the Iraqi population.
Methods
The present case-control research involved 160 patients (80 with NMIBC and 80 with MIBC) from the Central Hospital of Tumor in Najaf Governorate, Iraq. The serum PChE level was determined by enzyme-linked immunosorbent assay (ELISA), while lipid profile parameters were measured using colorimetric assay techniques.
Results
The estimation of demographic and biochemical data revealed significant differences in smoking, PChE, AIP, very low-density lipoprotein (VLDL), high-density lipoprotein (HDL), Triglyceride (TG), and Total cholesterol (TC) in NMIBC patients compared to those in the MIBC group. The logistic regression analysis of AIP, CRI-I, CRI-II, and AC levels revealed a significant association with MIBC at 4, 3, and 1 fold, respectively, while no association was found with PChE levels.
Conclusion
In the present study, the lipid indices' levels of AIP, CRI-II, and AC are associated with the development of MIBC and could be used to help physicians assess and confirm the presence of MIBC, while PChE failed to associate with the development of the disease.
Schlagwörter
Zitieren
APA
Smeasm, H. N., Al-timimi, R. J. M., & Mohammed, S. H. (2025). Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer. Journal of BioScience and Biotechnology. https://doi.org/10.69085/jbb20251007
Vancouver
Smeasm HN, Al-timimi RJM, Mohammed SH. Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer. Journal of BioScience and Biotechnology. 2025. doi:10.69085/jbb20251007
BibTeX
@article{Smeasm2025,
author = {Smeasm, Hasan N. and Al-timimi, Raid J. M. and Mohammed, Saif Hameed},
title = {Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer},
journal = {Journal of BioScience and Biotechnology},
year = {2025},
doi = {10.69085/jbb20251007}
}
EUVIMED